PRECIPIO, INC. Professional Fees
PRECIPIO, INC. (PRPO) reported Professional Fees of $87.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-14
- PRECIPIO, INC. professional fees for the quarter ending 2026-06-30 was $34.00K, a 49.25% decline year-over-year.
- PRECIPIO, INC. professional fees for the quarter ending 2026-03-31 was $53.00K, a 18.46% decline year-over-year.
- PRECIPIO, INC. professional fees for the quarter ending 2025-12-31 was $61.00K, a 20.78% decline year-over-year.
- PRECIPIO, INC. professional fees for the quarter ending 2025-09-30 was $48.00K, a 17.24% decline year-over-year.
- PRECIPIO, INC. professional fees for fiscal 2025 was $241.00K, a 37.56% decline from fiscal 2024.
- PRECIPIO, INC. professional fees for fiscal 2024 was $386.00K, a 118.08% increase from fiscal 2023.
- PRECIPIO, INC. professional fees for fiscal 2023 was $177.00K.
- PRECIPIO, INC. professional fees for fiscal 2021 was $150.00K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2026-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $87.00K 10-Q · filed 2026-08-14 | $148.00K derived: sum of 3 quarters · filed 2026-08-14 | $196.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $53.00K 10-Q · filed 2026-05-14 | $114.00K derived: sum of 2 quarters · filed 2026-05-14 | $162.00K derived: sum of 3 quarters · filed 2026-05-14 | $229.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $109.00K derived: sum of 2 quarters · filed 2026-03-30 | $176.00K derived: sum of 3 quarters · filed 2026-08-14 | $241.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $115.00K derived: sum of 2 quarters · filed 2026-08-14 | $180.00K 10-Q · filed 2025-11-14 | $257.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $132.00K 10-Q · filed 2026-08-14 | $209.00K derived: sum of 3 quarters · filed 2026-08-14 | $267.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $65.00K 10-Q · filed 2026-05-14 | $142.00K derived: sum of 2 quarters · filed 2026-05-14 | $200.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $135.00K derived: sum of 2 quarters · filed 2026-03-30 | $386.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $309.00K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $251.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $177.00K 10-K · filed 2025-03-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $150.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $150.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $150.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $150.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |